Clinical trial
Phase I/II Study of JR-171 ㏌ Patients With Mucopolysaccharidosis Type I
NCT04227600 is registered in ClinicalTrials.gov with JCR Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Study of JR-171 ㏌ Patients With Mucopolysaccharidosis Type I
- Lead sponsor
- JCR Pharmaceuticals Co., Ltd.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 1, 2020
- Completion date
- August 2, 2022
- Enrollment
- 18 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.